Baijin Life Science Holdings Limited
MNNGF
$0.08
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 96.07% | -2.79% | -191.99% | -496.02% | -186.16% |
| Total Depreciation and Amortization | 246.45% | 252.68% | 260.98% | 147.45% | 35.62% |
| Total Amortization of Deferred Charges | -131.87% | -31.96% | -- | -- | -- |
| Total Other Non-Cash Items | 88.61% | 51.33% | -60.94% | 22.69% | 39.54% |
| Change in Net Operating Assets | -328.50% | -382.69% | 72.30% | 454.19% | 1,166.07% |
| Cash from Operations | -374.74% | -156.27% | -29.70% | 35.85% | 69.92% |
| Capital Expenditure | -1,272.05% | -1,360.61% | -2,000.00% | -1,285.29% | -573.53% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -0.09% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 21.41% | -92.35% | -96.54% | -96.40% | -96.25% |
| Cash from Investing | -117.97% | -91.56% | -88.08% | -87.32% | -86.55% |
| Total Debt Issued | 286.11% | 193.60% | 125.23% | 79.48% | 10.85% |
| Total Debt Repaid | -459.70% | -21.19% | 78.86% | 93.88% | 96.31% |
| Issuance of Common Stock | -- | -- | -- | -62.08% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -280.31% | -145.57% | -115.96% | -123.34% | -279.10% |
| Cash from Financing | 4,976.89% | 85,222.22% | 2,563.61% | 557.58% | -77.76% |
| Foreign Exchange rate Adjustments | 94.51% | -102.65% | -4,450.00% | -9,100.00% | -1,363.75% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 393.56% | -36.28% | -86.84% | -100.58% | -119.12% |